期刊文献+

一氧化氮在舒芬太尼后处理减轻心脏瓣膜置换术患者心肌缺血再灌注损伤中的作用 被引量:2

Role of nitric oxide in reduction of myocardial ischemia-reperfusion injury by sufentanil postconditioning in cardiac valve replacement patients under cardiac pulmonary bypass
下载PDF
导出
摘要 目的:评价一氧化氮(NO)在舒芬太尼后处理减轻体外循环(CPB)下心脏瓣膜置换术患者心肌缺血再灌注损伤中的作用。方法:择期行心脏瓣膜置换术患者60例,年龄19~64岁,ASAⅡ~Ⅲ级,心功能Ⅱ~Ⅲ级。随机分为对照组(c组)、舒芬太尼0.5μg/kg组(S,组)、1.0μg/kg组(S:组)和2.0μg/kg组(S,组),每组15例。S1、S2、S3组于主动脉开放前5min时经主动脉根部分别输注舒芬太尼0.5、1.0和2.0μg/kg,稀释容量为2ml/kg,输注时间2min,C组用相同方法给予等容量0.9%氯化钠注射液。于麻醉诱导前(To)、主动脉开放后2h(T,)、4h(T:)、8h(T])、24h(T4)、48h(1'5)抽取桡动脉血,测定血浆心肌肌钙蛋白I(cTnI)、NO水平和肌酸磷酸激酶同工酶(CK—MB)、一氧化氮合酶(NOS)活力。记录患者血流动力学参数、CPB时间、主动脉阻断时间、气管导管拔出时间、ICU停留时间、术后24h心肌收缩力评分、术后24h引流量及心脏自动复跳率。结果:与C组比较:S1组T1-3,时cTnI、CK—MB均降低,NOS、NO均升高(P〈0.01);S2、S3组T。时cTnI、CK—MB均降低,T。时NOS、NO均升高(P〈0.01),气管导管拔出时间、ICU停留时间和术后24h心肌收缩力评分均降低(P〈0.05-P〈0.01)。与s,组比较,S2、S3组T4,5时cTnI和CK-MB均降低,L3-4时NOS、NO均升高,术后24h心肌收缩力评分均降低(P〈0.05~P〈0.01)。S2与S。3差异均无统计学意义(P〉0.05)。结论:舒芬太尼后处理通过激活NOS/NO信号通路,减轻CPB心脏瓣膜置换患者心肌缺血再灌注损伤,且有剂量依赖性和封顶效应。 Objective:To investigate the role of nitric oxide(NO) in reduction of myocardial ischemia-reperfusion(I/R) injury by sufentanil postconditioning in cardiac valve replacement patients under cardiac pulmonary bypass (CPB). Methods:Sixty patients (ASA grade II or III, NYHA class II or III ) of both sexes, aged 19-64, scheduled for cardiac valve replacement were randomly divided into 4 groups( n = 15 each) :control group( group C ), sufentanil 0.5 μg/kg group ( group S1 ), sufentanil 1.0 μg/kg group ( group Sz ) and snfentanil 2.0 μg/kg group( group S3 ). In groups S1, S2 and S3, sufentanil 0.5,1.0 and 2.0 μg/kg were infused over 2 min via aortic root 5 min before aortic unclamping respectively. In group C, the equal volume of normal saline (2 ml/kg) was infused instead of sufentanil. Blood samples were taken from radial artery before induction of anesthesia( To ) and at 2 h ( T1 ), 4 h ( T2 ), 8 h ( T3 ), 24 h (T4) and 48 h (T5 ) after aortic unclamping for determination of plasma concentrations of cardiac troponin-I (cTnI) and NO and activities of creatine kinase isoenzyme-MB(CK-MB) and nitric oxide synthase(NOS). The hemodynamic parameters, duration of CPB, time of aortic clamping, extubation time, duration of stay in ICU, and myocardial contractility score and volume of drainage at 24 h after the operation were recorded. The restoration of spontaneous heart beat were observed. Results: The plasma cTnI concentrations and CK- MB activity were significantly lower,while the plasma NO concentrations and NOS activity were significantly higher at T1-3 in group Sl than that in group C (P 〈 0.01 ). The plasma cTnI concentration and CK-MB activity were significantly lower at T1-5 , the plasma NO concentrations and NOS activity were significantly higher at T1-4,the extubation time and duration of stay in ICU were significantly shorter, and the myocardial contractility score at 24 h after the operation were significantly lower in gr
出处 《蚌埠医学院学报》 CAS 2013年第10期1291-1295,共5页 Journal of Bengbu Medical College
关键词 再灌流损伤 心脏瓣膜置换术 心肌保护 一氧化氮 舒芬太尼 sufentanil ischemia-reperfusion injury cardiac valve replacement surgery nitric oxide myocardial protection
  • 相关文献

参考文献17

  • 1Chen Z , Li T, Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat heart[J].J Surg Res,2008, 145 (2) :287 - 294. 被引量:1
  • 2翟明玉,顾尔伟,张雷,陈立建,朱燕,吴云,刘训芹.瑞芬太尼后处理对CPB心内直视手术患者心肌缺血再灌注损伤的影响[J].中华麻醉学杂志,2010,30(8):931-934. 被引量:2
  • 3Wu Y, Gu EW, Zhu Y, et al. Sufentanil limits the myocardial infarct size by preservation of the phosphorylated connexin 43[J].Int Immunopharmacol ,2012,13 (3) :341 - 346. 被引量:1
  • 4Chen QL,Gu EW,Zhang L,et al. Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemialreperfusion injury by altering glycogen synthase kinase-3J3[J]. Acta Anaesthesiol Scand,2013,57(2) :236 -242. 被引量:1
  • 5朱燕,顾尔伟,方卫平,吴云,张雷,刘训芹,翟明玉.诱导型一氧化氮合酶在舒芬太尼预处理减轻大鼠心肌缺血再灌注损伤中的作用[J].中华麻醉学杂志,2011,31(1):95-98. 被引量:2
  • 6Gross ER, Hsu AK, Grass GJ. Opioid-induced cardioprotection occursvia glycogen synthase KinaseJ3 inhibition during reperfusion in intact rat hearts[J]. Cric Res, 2004 , 94 ( 7 ) : 960 -966. 被引量:1
  • 7FellahiJ, Hedoire F, Le Manach Y, et al. Determination of the threshold of cardiac troponin I associated with an adverse postoperative outcome after cardiac surgery: a comparative study between coronary artery bypass graft, valve surgery and combined cardiac surgery[J] . Critical Care ,2007,11 (5) :6126 - 6135. 被引量:1
  • 8Burwell LS, Brookes PS. Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury[J]. Antioxid Redox Signal,2008,1O(3) :579 -599. 被引量:1
  • 9Kiziltepe U, Tunctan B, Eyileten ZB, et al. Efficiency of L?arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts[J]. Mol cell Biochem, 2004 , 97 ( 1 ) : 93 - 100. 被引量:1
  • 10Penna C, Cappello S, Mancardi D, et al. Postconditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/ cGMP pathway[J]. Basic Res Cardiol,2006,101(2) :168 -179. 被引量:1

二级参考文献40

  • 1黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1337
  • 2张野,陈志武.瑞芬太尼预处理对大鼠心肌缺血再灌注损伤的影响[J].中华麻醉学杂志,2005,25(6):449-452. 被引量:27
  • 3陈立建,顾尔伟,张野,李锐,陈齐,张健.瑞芬太尼预处理对患儿体外循环诱导心肌缺血再灌注损伤的影响[J].中华麻醉学杂志,2007,27(5):431-434. 被引量:9
  • 4Wong GT,Li R,Jiang LL,et al.Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation.Acta Anaesthesiol Scand,2010,54(4):510-518. 被引量:1
  • 5Steinlechner B,Dworschak M,Birkenberg B,et al.Low-dose remifentanil to suppress hemodynamic responses to noxious stimuli in cardiac surgery:a dose-finding study.Br J Anaesth,2007,98(5):598-603. 被引量:1
  • 6Gross ER,Hsu AK,Grss GJ.Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.Circ Res,2004,94 (7):960-966. 被引量:1
  • 7Lucchinetti E,da Silva R,Pasch T,et al.Anaesthetic preconditioning but not postconditioning prevents early activation of the deleterious cardiac remodeling programme:evidence of opposing genomic responses in cardioprotection by pre-and postconditioning.Br J Anaesth,2005,95 (2):140-152. 被引量:1
  • 8Fellahi JL,Gue X,Richonne X,et al.Short-and long-term prognostic value of postoperative cardiac troponin Ⅰ concentration in patients undergoing coronary artery bypass grafting.Anesthesiology,2003,99(2):270-274. 被引量:1
  • 9Zhao ZQ,Corvera JS,Halkos ME,et al.Inhibition of myocardial injury by ischemic postconditioning during reperfusion:comparison with ischemic preconditioning.Am J Physiol Heart Circ Physiol,2003,285 (2):H579-H588. 被引量:1
  • 10Zhang Y,Irwin MG,Wong TM.Remifentanil preconditioning confers cardioprotection via cardiac κ-and δ-opioid receptors.Anesthesiology,2005,102(2):371-378. 被引量:1

共引文献17

同被引文献15

  • 1陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775. 被引量:2785
  • 2中华医学会.临床诊疗指南-心血管内科分册[M].北京:人民卫生出版社,2009:1-5. 被引量:5
  • 3Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia dur- ing cardiopulmonary bypass is an independent risk factor for mortal- ity in patients undergoing cardiac surgery[ J. J Thorac Cardiovasc Surg, 2005, 130(4) : 1144. 被引量:1
  • 4Hadour G, Ferrera R, Sebbag L, et al. hnproved myocardial toler- ance to ischaemia in the diabetic rabbit [ J]. J Mol Cell Cardiol, 1998, 30(9) :1869-1875. 被引量:1
  • 5Ascione R, Rogers CA, Rajakaruna C, et al. Inadequate blood glucose control is associated with in-hospital mortality and morbidi- ty in diabetic and nondiabetic patients undergoing cardiac surgery [Jl. Circulation, 2008, 118(2) : 113-123. 被引量:1
  • 6Van Den Berghe G, Wouters P, Weekers F, et al. Intensive insu- lin therapy in critically ill patients[ J ]. N Engl J Med, 2001, 345 (19) : 1359-1367. 被引量:1
  • 7Murkin JM. Pro: tight intraoperative glucose control improves out- come in cardiovascular surgery [ J ]. J Cardiothorac Vasc Anesth, 2000, 14(4) : 475-478. 被引量:1
  • 8Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in Critically ill patients[ J]. N Engl J Med, 2009,360(13) : 1283-1297. 被引量:1
  • 9Report of the expert committee on the diagnosis and classification of diabetes mellitus [ J ]. Diabetes Care, 2000, 23 ( Suppl 1 ) : s4-19. 被引量:1
  • 10Boord JB, Graber AL, Christman JW, et al. Practical management of diabetes in critically ill patients [ J 1. Am J Respir Crit Care Med, 2001, 164 ( 10 Ptl ) : 1763-1767. 被引量:1

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部